Dulaglutide Modulates the Development of Tissue-Infiltrating Th1/Th17 Cells and the Pathogenicity of Encephalitogenic Th1 Cells in the Central Nervous System.
Chiou, Hsin-Ying Clair
Dulaglutide Modulates the Development of Tissue-Infiltrating Th1/Th17 Cells and the Pathogenicity of Encephalitogenic Th1 Cells in the Central Nervous System. [electronic resource] - International journal of molecular sciences Mar 2019
Publication Type: Journal Article
1422-0067
10.3390/ijms20071584 doi
Animals
Central Nervous System--pathology
Chemotaxis--drug effects
Dendritic Cells--drug effects
Disease Progression
Down-Regulation--drug effects
Encephalomyelitis, Autoimmune, Experimental--drug therapy
Glucagon-Like Peptides--administration & dosage
Granulocyte-Macrophage Colony-Stimulating Factor--pharmacology
Immunization
Immunoglobulin Fc Fragments--administration & dosage
Lymphocyte Subsets--drug effects
Macrophages--drug effects
Male
Mice, Inbred C57BL
Myelin-Oligodendrocyte Glycoprotein
Recombinant Fusion Proteins--administration & dosage
Th1 Cells--drug effects
Th17 Cells--drug effects
Glucagon-Like Peptide-1 Receptor Agonists
Dulaglutide Modulates the Development of Tissue-Infiltrating Th1/Th17 Cells and the Pathogenicity of Encephalitogenic Th1 Cells in the Central Nervous System. [electronic resource] - International journal of molecular sciences Mar 2019
Publication Type: Journal Article
1422-0067
10.3390/ijms20071584 doi
Animals
Central Nervous System--pathology
Chemotaxis--drug effects
Dendritic Cells--drug effects
Disease Progression
Down-Regulation--drug effects
Encephalomyelitis, Autoimmune, Experimental--drug therapy
Glucagon-Like Peptides--administration & dosage
Granulocyte-Macrophage Colony-Stimulating Factor--pharmacology
Immunization
Immunoglobulin Fc Fragments--administration & dosage
Lymphocyte Subsets--drug effects
Macrophages--drug effects
Male
Mice, Inbred C57BL
Myelin-Oligodendrocyte Glycoprotein
Recombinant Fusion Proteins--administration & dosage
Th1 Cells--drug effects
Th17 Cells--drug effects
Glucagon-Like Peptide-1 Receptor Agonists